Tower Research Capital LLC TRC Sells 238 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Tower Research Capital LLC TRC lessened its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 32.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 502 shares of the company’s stock after selling 238 shares during the period. Tower Research Capital LLC TRC’s holdings in U.S. Physical Therapy were worth $66,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in USPH. NumerixS Investment Technologies Inc purchased a new stake in U.S. Physical Therapy during the 2nd quarter worth approximately $61,000. Ladenburg Thalmann Financial Services Inc. grew its position in U.S. Physical Therapy by 74.0% during the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 548 shares of the company’s stock worth $67,000 after purchasing an additional 233 shares during the last quarter. Resources Investment Advisors LLC. grew its position in U.S. Physical Therapy by 96.6% during the 2nd quarter. Resources Investment Advisors LLC. now owns 816 shares of the company’s stock worth $100,000 after purchasing an additional 401 shares during the last quarter. Nisa Investment Advisors LLC purchased a new stake in U.S. Physical Therapy during the 3rd quarter worth approximately $214,000. Finally, LPL Financial LLC purchased a new stake in U.S. Physical Therapy during the 2nd quarter worth approximately $227,000.

Several research firms have weighed in on USPH. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Thursday. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 target price on the stock in a research report on Friday, November 8th. Finally, ValuEngine raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. One equities research analyst has rated the stock with a sell rating and three have assigned a buy rating to the stock. U.S. Physical Therapy currently has an average rating of “Buy” and a consensus price target of $127.20.

NYSE:USPH opened at $116.86 on Friday. The company has a market cap of $1.48 billion, a PE ratio of 40.08, a P/E/G ratio of 3.30 and a beta of 1.09. U.S. Physical Therapy, Inc. has a twelve month low of $98.69 and a twelve month high of $148.48. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.48. The company’s 50 day moving average is $129.00 and its two-hundred day moving average is $126.57.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.71 EPS for the quarter, meeting the consensus estimate of $0.71. The business had revenue of $117.30 million for the quarter, compared to the consensus estimate of $121.28 million. U.S. Physical Therapy had a net margin of 6.36% and a return on equity of 16.57%. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.64 EPS. As a group, analysts expect that U.S. Physical Therapy, Inc. will post 2.86 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Monday, November 18th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 45.28%.

In other news, Director Mark J. Brookner sold 1,000 shares of the company’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $116.25, for a total value of $116,250.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Harry S. Chapman acquired 2,400 shares of the company’s stock in a transaction dated Monday, November 11th. The stock was acquired at an average cost of $117.00 per share, for a total transaction of $280,800.00. The disclosure for this purchase can be found here. Insiders sold a total of 4,476 shares of company stock worth $515,700 over the last ninety days. Insiders own 2.50% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: Trading signals using Bollinger bands

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.